Consensus guidelines for eligibility assessment of pathogenic variants to antisense oligonucleotide treatments
David Cheerie, Margaret M. Meserve, Danique Beijer…·Marlen C. Lauffer
The paper presents consensus guidelines for assessing pathogenic variants' eligibility for antisense oligonucleotide treatments, including classification criteria and considerations for different therapeutic approaches.